Literature DB >> 15673056

Alcohol intake and insulin resistance. A cross-sectional study.

R Villegas1, A Salim, D O'Halloran, I J Perry.   

Abstract

BACKGROUND AND AIM: The development of insulin resistance is a critical step in the pathogenesis of type 2 diabetes. The effect of alcohol intake on insulin sensitivity/resistance is not well defined. The aim of this study was to examine the association between alcohol intake and insulin resistance in a sample of middle-aged men and women with data on a wide range of potential confounding factors, including diet.
METHODS: We performed a cross sectional study involving a group of 1018 men and women, sampled from 17 general practice lists in the South of Ireland, with a response rate of 69%. Participants completed a detailed health and lifestyle questionnaire and a food frequency questionnaire and provided fasting blood samples for analysis of glucose and insulin. Insulin resistance was estimated on the basis of fasting glucose and insulin, using the glucose homeostasis model (HOMA scores). Insulin resistance was defined as the upper quartile of the HOMA scores.
RESULTS: We found evidence of a U-shaped relationship between alcohol intake and insulin resistance fitted as a continuous variable (HOMA scores) with lowest levels in light drinkers (between 0.5 to 0.99 units per day) relative to the other drinking categories. However no significant association between alcohol intake and HOMA score was observed in fully adjusted analyses, including adjustment for dietary saturated fat and fruit and vegetables intake. In logistic regression analysis with insulin resistance (categorical) as the dependent variable, we observed that ex-drinkers were at higher risk of insulin resistance compared to occasional drinkers independently of age, sex, BMI and waist circumference, (OR=2.4, 95% CI, 1.1-5.7, p=0.04). On further adjustment for potential confounders including diet this association was also attenuated and was non-significant.
CONCLUSIONS: The reported effects of alcohol intake on insulin resistance may be confounded by other aspects of lifestyle, especially diet.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15673056     DOI: 10.1016/s0939-4753(04)80049-8

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  7 in total

1.  Alcohol consumption and atherosclerotic burden in the proximal thoracic aorta.

Authors:  Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Atherosclerosis       Date:  2011-08-16       Impact factor: 5.162

2.  Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men.

Authors:  Raquel Villegas; Yong-Bing Xiang; Gong Yang; Qiuyin Cai; Sergio Fazio; MacRae F Linton; Tom Elasy; Wang-Hong Xu; Honglan Li; Hui Cai; Yu-Tang Gao; Wei Zheng; Xiao Ou Shu
Journal:  Metab Syndr Relat Disord       Date:  2009-02       Impact factor: 1.894

3.  Access schedules mediate the impact of high fat diet on ethanol intake and insulin and glucose function in mice.

Authors:  Caitlin R Coker; Elizabeth A Aguilar; Angela E Snyder; Sarah S Bingaman; Nicholas M Graziane; Kirsteen N Browning; Amy C Arnold; Yuval Silberman
Journal:  Alcohol       Date:  2020-03-26       Impact factor: 2.405

Review 4.  Alcohol consumption: can we safely toast to our health?

Authors:  Christopher Griffith; Douglas Bogart
Journal:  Mo Med       Date:  2012 Nov-Dec

Review 5.  Impact of Alcohol on Glycemic Control and Insulin Action.

Authors:  Jennifer L Steiner; Kristen T Crowell; Charles H Lang
Journal:  Biomolecules       Date:  2015-09-29

6.  Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe?

Authors:  Alistair Vw Nunn; Jimmy D Bell; Geoffrey W Guy
Journal:  Nutr Metab (Lond)       Date:  2009-04-16       Impact factor: 4.169

7.  The cumulative effect of core lifestyle behaviours on the prevalence of hypertension and dyslipidemia.

Authors:  Raquel Villegas; Patricia M Kearney; Ivan J Perry
Journal:  BMC Public Health       Date:  2008-06-13       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.